DrugMapper


Display Options: Drug type Therapeutic Area Route of administration Mechanism of Action Indication Status		Total: 10647


Antibody Approved Unknown UNKNOWN Blast Crisis; Hematologic Neoplasms; Leukemia, Biphenotypic, Acute; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Neoplasms; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor Cell Lymphoblastic Leukemia-Lymphoma CD22 binding agent


Small molecule Approved Unknown Unknown Bacterial Infections; Renal Insufficiency; Urinary Tract Infections Carbepenem-hydrolyzing beta-lactamase KPC inhibitor


Small molecule Approved Unknown TOPICAL Wounds and Injuries; Impetigo DNA gyrase inhibitor


Combination Approved Unknown Unknown Unknown Unknown


Small molecule Approved Unknown ORAL Kidney Diseases; Liver Diseases; Aspergillosis, Allergic Bronchopulmonary; Muscular Dystrophies, Limb-Girdle; Muscular Dystrophies; Muscular Dystrophy, Duchenne Glucocorticoid receptor agonist


Unknown Approved Unknown Unknown Unknown Unknown


Enzyme Unknown Unknown Unknown Neuronal Ceroid-Lipofuscinoses Polypeptides proteolytic enzyme


Small molecule Approved Unknown Unknown Liver Diseases; Biliary Tract Neoplasms; Malignant Carcinoid Syndrome; Carcinoid Heart Disease; Neuroendocrine Tumors Tryptophan 5-hydroxylase inhibitor


Small molecule Approved Unknown OPHTHALMIC Glaucoma; Glaucoma, Open-Angle; Ocular Hypertension Prostanoid FP receptor agonist


Enzyme Approved Unknown INJECTION Unknown Unknown


Small molecule Approved Unknown Unknown Glaucoma, Open-Angle; Corneal Edema; Fuchs' Endothelial Dystrophy; Glaucoma Unknown


Small molecule Approved Unknown ORAL Chagas Disease; Leishmaniasis; Trypanosomiasis Unknown


Small molecule Approved Unknown Unknown Cachexia Ghrelin receptor agonist


Antibody Approved Unknown INJECTION; INTRAVENOUS Carcinoma, Pancreatic Ductal; Chordoma; Fallopian Tube Neoplasms; Glioma; Head and Neck Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Melanoma; Meningioma; Mesothelioma; Peritoneal Neoplasms; Prostatic Neoplasms; Skin Neoplasms; Adenocarcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Gestational Trophoblastic Disease; Glioblastoma; Hemangiosarcoma; Hodgkin Disease; Leiomyosarcoma; Lymphoma; Multiple Myeloma; Nasopharyngeal Neoplasms; Neuroendocrine Tumors; Osteosarcoma; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Small Cell Lung Carcinoma; Thymoma; Urinary Bladder Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colonic Neoplasms; Lymphoma, Large B-Cell, Diffuse; Ovarian Neoplasms; Stomach Neoplasms; Urogenital Neoplasms; Carcinoma, Merkel Cell; Carcinoma, Transitional Cell; Neoplasms Programmed cell death 1 ligand 1 other

Antibody

Approved

Unknown

INJECTION; INTRAVENOUS

Carcinoma, Pancreatic Ductal; Chordoma; Fallopian Tube Neoplasms; Glioma; Head and Neck Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Melanoma; Meningioma; Mesothelioma; Peritoneal Neoplasms; Prostatic Neoplasms; Skin Neoplasms; Adenocarcinoma; Carcinoma, Adenoid Cystic; Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Colorectal Neoplasms; Endometrial Neoplasms; Esophageal Neoplasms; Gestational Trophoblastic Disease; Glioblastoma; Hemangiosarcoma; Hodgkin Disease; Leiomyosarcoma; Lymphoma; Multiple Myeloma; Nasopharyngeal Neoplasms; Neuroendocrine Tumors; Osteosarcoma; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Rectal Neoplasms; Small Cell Lung Carcinoma; Thymoma; Urinary Bladder Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colonic Neoplasms; Lymphoma, Large B-Cell, Diffuse; Ovarian Neoplasms; Stomach Neoplasms; Urogenital Neoplasms; Carcinoma, Merkel Cell; Carcinoma, Transitional Cell; Neoplasms

Programmed cell death 1 ligand 1 other


Protein Approved Unknown ORAL; SUBCUTANEOUS Bone Diseases, Metabolic; Depressive Disorder, Major; Diabetes Mellitus, Type 1; Parkinson Disease; Alzheimer Disease; Non-alcoholic Fatty Liver Disease; Obesity; Diabetes Mellitus; Diabetes Mellitus, Type 2 Glucagon-like peptide 1 receptor agonist


Small molecule Approved Unknown Unknown Hepatitis C; Hepatitis C, Chronic Hepatitis C virus serine protease, NS3/NS4A inhibitor


Protein Approved Unknown SUBCUTANEOUS Fractures, Bone; Osteoporosis, Postmenopausal; Osteoporosis Parathyroid hormone receptor agonist


Small molecule Approved Unknown Unknown Renal Insufficiency, Chronic; Kidney Diseases; Liver Diseases; Hepatitis C; Hepatitis C, Chronic Nonstructural protein 5A inhibitor


Small molecule Approved Unknown ORAL Communicable Diseases; Glioblastoma; Leukemia; Leukemia, Prolymphocytic; Multiple Myeloma; Neoplasms; Arthritis, Rheumatoid; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Graft vs Host Disease; Hematologic Neoplasms; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Ovarian Neoplasms; Pancreatic Neoplasms; Waldenstrom Macroglobulinemia; Lymphoma, Large B-Cell, Diffuse; Severe Acute Respiratory Syndrome; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell Tyrosine-protein kinase BTK inhibitor

Small molecule

Approved

Unknown

ORAL

Communicable Diseases; Glioblastoma; Leukemia; Leukemia, Prolymphocytic; Multiple Myeloma; Neoplasms; Arthritis, Rheumatoid; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Graft vs Host Disease; Hematologic Neoplasms; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Ovarian Neoplasms; Pancreatic Neoplasms; Waldenstrom Macroglobulinemia; Lymphoma, Large B-Cell, Diffuse; Severe Acute Respiratory Syndrome; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell

Tyrosine-protein kinase BTK inhibitor


Small molecule Approved Unknown Unknown Hypersensitivity; Substance Withdrawal Syndrome; Cocaine-Related Disorders; Opioid-Related Disorders Unknown


Small molecule Approved Unknown Unknown Hematologic Neoplasms; Liver Diseases; Multiple Myeloma; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Myelodysplastic Syndromes; Leukemia; Neoplasms Unknown


Small molecule Approved Unknown ORAL Liver Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Rectal Neoplasms; Blast Crisis; Myelodysplastic Syndromes; Leukemia; Leukemia, Mast-Cell; Leukemia, Myeloid, Acute; Mastocytosis; Mastocytosis, Systemic; Neoplasms Platelet-derived growth factor receptor inhibitor


Small molecule Approved Unknown INTRAVENOUS Kidney Diseases; Liver Diseases; Brain Injuries; Cerebral Hemorrhage; Stroke; Ischemic Stroke; Amyotrophic Lateral Sclerosis Unknown


Small molecule Approved Unknown Unknown Fallopian Tube Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Neoplasms; Peritoneal Neoplasms; Rectal Neoplasms; Sarcoma, Ewing; Stomach Neoplasms; Urogenital Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Colorectal Neoplasms; Endometrial Neoplasms; Glioblastoma; Head and Neck Neoplasms; Lymphoma; Melanoma; Mesothelioma; Pancreatic Neoplasms; Prostatic Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Hereditary Breast and Ovarian Cancer Syndrome; Ovarian Neoplasms; Prostatic Neoplasms, Castration-Resistant; Small Cell Lung Carcinoma; Neoplasms Poly [ADP-ribose] polymerase-1 inhibitor

Small molecule

Approved

Unknown

Fallopian Tube Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Lung Neoplasms; Peritoneal Neoplasms; Rectal Neoplasms; Sarcoma, Ewing; Stomach Neoplasms; Urogenital Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Squamous Cell; Colorectal Neoplasms; Endometrial Neoplasms; Glioblastoma; Head and Neck Neoplasms; Lymphoma; Melanoma; Mesothelioma; Pancreatic Neoplasms; Prostatic Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Hereditary Breast and Ovarian Cancer Syndrome; Ovarian Neoplasms; Prostatic Neoplasms, Castration-Resistant; Small Cell Lung Carcinoma; Neoplasms

Poly [ADP-ribose] polymerase-1 inhibitor


Small molecule Approved Unknown Unknown Carcinoma; Colorectal Neoplasms; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Ovarian Neoplasms; Carcinoma, Non-Small-Cell Lung; Glioblastoma; Hemangiosarcoma; Prostatic Neoplasms; Breast Neoplasms; Neoplasms Epidermal growth factor receptor erbB1 inhibitor


Unknown Approved Unknown Unknown Unknown Unknown


Small molecule Approved Unknown ORAL Leukemia, Myeloid, Acute Smoothened homolog antagonist


Small molecule Approved Unknown Unknown Unknown Unknown


Oligonucleotide Approved Unknown Unknown Amyloid Neuropathies, Familial; Amyloidosis Transthyretin mRNA RNAi inhibitor


Small molecule Approved Unknown Unknown Cystic Fibrosis Cystic fibrosis transmembrane conductance regulator positive modulator


Oligonucleotide Approved Unknown Unknown Amyloid Neuropathies, Familial; Amyloidosis Transthyretin ANTISENSE inhibitor

Antibody

Unknown

Carcinoma, Merkel Cell; Carcinoma, Renal Cell; Diffuse Intrinsic Pontine Glioma; Fallopian Tube Neoplasms; Hepatitis B, Chronic; HIV Infections; Multiple Myeloma; Neoplasm Metastasis; Ovarian Neoplasms; Skin Neoplasms; Breast Neoplasms; Glioblastoma; Hemangiosarcoma; Hodgkin Disease; Lymphoma; Melanoma; Oropharyngeal Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Lung Neoplasms; Neoplasms

Programmed cell death protein 1 inhibitor


Small molecule Approved Unknown Unknown Carcinoma, Non-Small-Cell Lung; Kidney Diseases; Liver Diseases; Blast Crisis; Myelodysplastic Syndromes; Leukemia, Myeloid, Acute; Neoplasms Tyrosine-protein kinase receptor FLT3 inhibitor


Antibody Approved Unknown Unknown Osteoarthritis, Knee; Pain; Migraine Disorders Calcitonin gene-related peptide inhibitor


Small molecule Unknown Unknown Unknown Smallpox; Virus Diseases Envelope phospholipase F13 (p37) inhibitor